Search reports.
Brazil In Vitro Diagnostics Market Size, Growth Report 2031
Get free sample report Request for Customiztion Buy Now

Brazil In Vitro Diagnostics Market Size, Growth Report 2031

Segments - Brazil In Vitro Diagnostics Market by Test Types (Molecular Diagnostics, Clinical Chemistry, Immunodiagnostics, Hematology, and Others), Products (Instrument, Reagent, and Others), Usability (Disposable IVD Devices and Reusable IVD Devices), Applications (Infectious Disease, Cardiology, Autoimmune Disease, Diabetes, Cancer/Oncology, Nephrology, and Others), End-users (Diagnostic Laboratories, Hospitals & Clinics, and Others), and Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 - 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-3443 | 4.5 Rating | 69 Reviews | 226 Pages | Format : PDF Excel PPT

Report Description


Brazil In Vitro Diagnostics Market Outlook 2031:

The Brazil in vitro diagnostics market size was valued at USD 1.70 Billion in 2022 and is projected to reach USD 2.53 Billion by 2031, expanding at a CAGR of 4.52% during the forecast period 2023 - 2031. The growth of the market is attributed to the rising interest of the researchers in molecular testing technologies.

In vitro diagnostics is defined as medical equipment that are used by hospital to perform diagnostic tests inside a laboratory. These tests are carried out on blood, urine, and tissue samples taken from a patient's body. Additionally, medical devices that perform in vitro diagnostics require the employment of a variety of technologies to carry out the tests.

Brazil In Vitro Diagnostics Market Outlook

In vitro diagnostics are used to diagnose infectious disorders, diabetes, cancer, cardiac problems, autoimmune diseases, nephrology, and HIV, among other medical conditions. However due to the COVID-19, several in vitro diagnostics services were negatively impacted. As a result, the total impact on the in vitro diagnostics industry was minimal as increasing demand for testing kits offset losses from lower demand for other services and products.

  • Rise in awareness about diagnostic services is driving the market growth.
  • Increasing government expenditure on healthcare is anticipated to boost the market expansion.
  • The accurate and quick test results supplement of in vitro diagnostics is propelling the growth of the industry.
  • Stringent regulations & policies can hamper the market growth.
  • Ongoing R&D on vitro diagnostics and lucrative opportunities for key players in the in vitro diagnostics market during the forecast period. 

Scope of the In Vitro Diagnostics Market Report

The report on the Brazil in vitro diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Brazil In Vitro Diagnostics Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Test Types (Molecular Diagnostics, Clinical Chemistry, Immunodiagnostics, Hematology, and Others), Products (Instrument, Reagent, and Others), Usability (Disposable IVD Devices and Reusable IVD Devices), Applications (Infectious Disease, Cardiology, Autoimmune Disease, Diabetes, Cancer/Oncology, Nephrology, and Others), and End-users (Diagnostic Laboratories, Hospitals & Clinics, and Others)

Country

Brazil

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Bio-Rad Laboratories Inc.; Roche Diagnostics; bioMérieux; Danaher Corporation; Becton, Dickinson and Company

Brazil In Vitro Diagnostics Market Segment Insights

Molecular diagnostics segment is expected to grow at a rapid pace

Based on test types, the market is divided into molecular diagnostics, clinical chemistry, immunodiagnostics, hematology, and others. The molecular diagnostics segment is expected to grow at a rapid pace during the forecast period due to rising prevalence of diabetes.

Moreover, molecular diagnostic equipment evaluates biological markers in the genome and proteome to identify diseases or mutations.

Brazil In Vitro Diagnostics Market Test Type

Reagents segment is projected to expand at a considerable CAGR

On the basis of products, the market is segregated into instrument, reagent, and others. The reagents segment is projected to expand at a considerable CAGR during the forecast period as reagents are a vital part of every in-vitro diagnostic test.

However, the instrument segment is anticipated to hold a key share of the market in the coming years owing to rise in focus  toward launching of new instruments. 

Disposable IVD segment is anticipated to account for a significant market share.

In terms of usability, the market is divided into disposable IVD devices and reusable IVD devices. The disposable IVD devices segment is anticipated to account for a significant market share during the forecast period due to easy availability of devices.

However, the IVD devices segment is projected to expand at a considerable CAGR during the forecast period owing to growing knowledge about the usage of these devices.

Infectious disease segment is expected to expand at a considerable CAGR

On the basis of applications, the market is segregated into infectious disease, cardiology, autoimmune disease, diabetes, cancer/oncology, nephrology, and others.

The infectious disease segment is projected to expand at a considerable CAGR during the forecast period due to rise in incidence of HIV, hepatitis, and other infectious disorders.

Brazil In Vitro Diagnostics Market Applications

Diagnostic laboratories segment is anticipated to account for a significant market share.

Based on end-users, the market is divided into diagnostic laboratories, hospitals & clinics, and others. The diagnostic laboratories segment is estimated to account for a significant market share during the forecast period.

Diagnostic laboratories employee highly experienced laboratory technicians who can execute complex in vitro diagnostic tests. The hospitals & clinics medical facilities receive a huge number of patient samples for in vitro diagnostic testing.

Segments

The Brazil in vitro diagnostics market has been segmented on the basis of

Test Types

  • Clinical Chemistry
  • Molecular Diagnostics
  • Immunodiagnostics
  • Hematology
  • Others

 Products

  • Instrument
  • Reagent
  • Others

Usability

  • Disposable IVD Devices
  • Reusable IVD Devices

 Applications

  • Infectious Disease
  • Diabetes, Cancer/Oncology
  • Cardiology, Autoimmune Disease
  • Nephrology
  • Others

End-users

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Others

 Country

  • Brazil

Key Players

Competitive Landscape

Key players competing in the Brazil in vitro diagnostics market are Bio-Rad Laboratories Inc.; Roche Diagnostics; bioMérieux; Danaher Corporation; Becton, Dickinson and Company.

The major companies are concentrating their efforts on growing technical breakthroughs in order to meet client demands, such as completely automated systems that eliminate human operations and consumables while providing quick and precise results.

Brazil In Vitro Diagnostics Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. In Vitro Diagnostics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. In Vitro Diagnostics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. In Vitro Diagnostics Market - Supply Chain
  4.5. Global In Vitro Diagnostics Market Forecast
     4.5.1. In Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. In Vitro Diagnostics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. In Vitro Diagnostics Market Absolute $ Opportunity
5. Global In Vitro Diagnostics Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. In Vitro Diagnostics Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global In Vitro Diagnostics Demand Share Forecast, 2019-2026
6. North America In Vitro Diagnostics Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America In Vitro Diagnostics Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America In Vitro Diagnostics Demand Share Forecast, 2019-2026
7. Latin America In Vitro Diagnostics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America In Vitro Diagnostics Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America In Vitro Diagnostics Demand Share Forecast, 2019-2026
8. Europe In Vitro Diagnostics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe In Vitro Diagnostics Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe In Vitro Diagnostics Demand Share Forecast, 2019-2026
9. Asia Pacific In Vitro Diagnostics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific In Vitro Diagnostics Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific In Vitro Diagnostics Demand Share Forecast, 2019-2026
10. Middle East & Africa In Vitro Diagnostics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa In Vitro Diagnostics Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa In Vitro Diagnostics Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global In Vitro Diagnostics Market: Market Share Analysis
  11.2. In Vitro Diagnostics Distributors and Customers
  11.3. In Vitro Diagnostics Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)

Methodology

Our Clients

Pfizer
The John Holland Group
Microsoft
Dassault Aviation
Nestle SA
General Electric
sinopec
Deloitte